Sofinnova Investments as of Dec. 31, 2023
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 60 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 24.5 | $437M | 1.4M | 316.51 | |
| Rayzebio | 8.4 | $150M | 2.4M | 62.17 | |
| Natera (NTRA) | 5.4 | $97M | 1.6M | 62.64 | |
| Ascendis Pharma A/S Sponsored Adr (ASND) | 5.3 | $95M | 754k | 125.95 | |
| Merck & Co (MRK) | 5.2 | $94M | 858k | 109.02 | |
| Aerovate Therapeutics (AVTE) | 4.8 | $85M | 3.8M | 22.63 | |
| AstraZeneca Sponsored Adr (AZN) | 3.2 | $57M | 851k | 67.35 | |
| Vera Therapeutics Cl A (VERA) | 3.0 | $53M | 3.5M | 15.38 | |
| Ideaya Biosciences (IDYA) | 2.9 | $52M | 1.5M | 35.58 | |
| ImmunoGen | 2.6 | $46M | 1.5M | 29.65 | |
| Intuitive Surgical (ISRG) | 2.4 | $43M | 127k | 337.36 | |
| Eli Lilly & Co. (LLY) | 2.1 | $38M | 65k | 582.92 | |
| Cytokinetics (CYTK) | 1.9 | $35M | 414k | 83.49 | |
| Celldex Therapeutics (CLDX) | 1.9 | $34M | 844k | 39.66 | |
| Cymabay Therapeutics | 1.9 | $33M | 1.4M | 23.62 | |
| Immatics NV SHS (IMTX) | 1.7 | $31M | 3.0M | 10.53 | |
| Sanofi Sponsored Adr (SNY) | 1.7 | $30M | 599k | 49.73 | |
| Inhibrx | 1.6 | $29M | 773k | 38.00 | |
| Kenvue (KVUE) | 1.5 | $26M | 1.2M | 21.53 | |
| Kura Oncology (KURA) | 1.3 | $24M | 1.7M | 14.38 | |
| Syndax Pharmaceuticals (SNDX) | 1.3 | $23M | 1.1M | 21.61 | |
| Marinus Pharmaceuticals | 1.1 | $20M | 1.9M | 10.87 | |
| Stryker Corporation (SYK) | 1.1 | $19M | 63k | 299.46 | |
| Incyte Corporation (INCY) | 1.0 | $19M | 297k | 62.79 | |
| Geron Corporation (GERN) | 1.0 | $19M | 8.8M | 2.11 | |
| Inozyme Pharma (INZY) | 1.0 | $18M | 4.3M | 4.26 | |
| Elanco Animal Health (ELAN) | 1.0 | $18M | 1.2M | 14.90 | |
| argenx SE Sponsored Adr (ARGX) | 1.0 | $17M | 45k | 380.43 | |
| Y Mabs Therapeutics | 0.8 | $15M | 2.2M | 6.82 | |
| Pharvaris N V (PHVS) | 0.8 | $14M | 510k | 28.05 | |
| Agenus Call Option | 0.8 | $14M | 17M | 0.83 | |
| Dyne Therapeutics (DYN) | 0.8 | $14M | 1.0M | 13.30 | |
| Savara (SVRA) | 0.6 | $11M | 2.4M | 4.70 | |
| Mirum Pharmaceuticals (MIRM) | 0.6 | $10M | 352k | 29.52 | |
| Cabaletta Bio (CABA) | 0.5 | $9.7M | 429k | 22.70 | |
| Immunovant (IMVT) | 0.5 | $9.4M | 223k | 42.13 | |
| Boston Scientific Corporation (BSX) | 0.4 | $7.6M | 131k | 57.81 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.4 | $7.1M | 175k | 40.76 | |
| MoonLake Immunotherapeutics Class A Ord (MLTX) | 0.4 | $6.9M | 114k | 60.39 | |
| Insulet Corporation (PODD) | 0.2 | $4.1M | 19k | 216.98 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.2 | $3.8M | 331k | 11.44 | |
| Bolt Biotherapeutics | 0.2 | $3.1M | 2.8M | 1.12 | |
| Nextcure (NXTC) | 0.2 | $3.0M | 2.7M | 1.14 | |
| Dex (DXCM) | 0.1 | $2.5M | 20k | 124.09 | |
| Cooper Companies | 0.1 | $1.5M | 4.0k | 378.44 | |
| Masimo Corporation (MASI) | 0.1 | $1.5M | 13k | 117.21 | |
| Nucana Sponsored Adr | 0.1 | $1.4M | 4.7M | 0.30 | |
| Fusion Pharmaceuticals | 0.1 | $1.2M | 125k | 9.61 | |
| Immatics NV *w Exp 07/01/2025 (IMTXW) | 0.1 | $930k | 318k | 2.92 | |
| Ikena Oncology (IKNA) | 0.0 | $716k | 364k | 1.97 | |
| Nucana Common Shares | 0.0 | $710k | 2.4M | 0.30 | |
| Pds Biotechnology Ord (PDSB) | 0.0 | $709k | 143k | 4.97 | |
| Penumbra (PEN) | 0.0 | $503k | 2.0k | 251.54 | |
| Galera Therapeutics (GRTX) | 0.0 | $448k | 3.1M | 0.15 | |
| Fulcrum Therapeutics (FULC) | 0.0 | $193k | 29k | 6.75 | |
| Pepgen (PEPG) | 0.0 | $157k | 23k | 6.80 | |
| Establishment Labs Holdings Ord (ESTA) | 0.0 | $79k | 3.1k | 25.89 | |
| Spruce Biosciences (SPRB) | 0.0 | $67k | 23k | 2.93 | |
| Soleno Therapeutics (SLNO) | 0.0 | $48k | 1.2k | 40.25 | |
| Vir Biotechnology (VIR) | 0.0 | $45k | 4.5k | 10.06 |
